相关实验视频

Updated: Jun 19, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.1K

骨髓瘤中与海斯相关基因的多组基因分析:一项多维综合研究揭示了药物敏感性和免疫微环境特征

Yang Yang1, Xinqiao Tang1, Zhong Liu2

  • 1Department of Orthopedic Surgery, Xiangtan Central Hospital, Xiangtan, Hunan, P.R. China.

Technology in cancer research & treatment
|April 17, 2025
PubMed
概括

这项研究揭示了骨髓瘤 (OS) 内的基因组修饰的空间差异,并开发了患者结果的预测模型. 这些发现支持针对个性化OS治疗的表观遗传免疫策略.

关键词:
表观遗传免疫调节基质子的修改 基质子的修改骨质肉瘤是骨质肉瘤的一种疾病.个性化治疗是个性化的治疗.预测模型的预测模型.一个单细胞RNA测序.瘤微环境是一个微环境.

更多相关视频

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

1.3K
Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics07:43

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

2.3K

相关概念视频

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...